Targovax ASA logo

TRVX - Targovax ASA News Story

NOK8.05 0.4  4.6%

Last Trade - 3:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £49.3m
Enterprise Value £46.2m
Revenue £238k
Position in Universe 989th / 1784

BRIEF-Targovax: Immune Activation Data In Patients Treated With ONCOS-102

Thu 4th January, 2018 6:21am
Jan 4 (Reuters) - TARGOVAX ASA  TRVX.OL : 
    * ANNOUNCES IMMUNE ACTIVATION DATA IN FIRST FOUR PATIENTS 
TREATED 
WITH ONCOS-102 
    * RESULTS ARE IN LINE WITH DATA REPORTED IN COMPLETED 
ALL-COMERS 
PHASE I TRIAL 
 
Source text for Eikon:  ID:nGNE78zRbC  
Further company coverage:  TRVX.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.